Mike Ross

Mike Ross is the Managing Partner at SV Life Sciences in San Mateo, California, with a background that includes senior leadership roles at SV Health Investors and as CEO of MetaXen and Arris Pharmaceutical. He has successfully invested in companies like Eyebiotech, Therini Bio, and Xilio Therapeutics, demonstrating a strong track record in the biotech sector. With a postdoc at Harvard University and a Ph.D. from Caltech, Mike Ross brings a wealth of experience to his current role, where he focuses on investing in companies at various stages, including Series B, Series A, and Seed, within the BioTech sector in the San Francisco Bay Area.